Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Summary

Day One (Nasdaq: DAWN) announced management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 4:00 p.m. EST.

A live webcast will be available via the Events section of the Day One Media & Investors page, and an archived replay will be available for 30 days after the live event.

BRISBANE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that management will participate in a fireside chat at the Piper Sandler 37^th Annual Healthcare Conference on Tuesday, December 2, 2025 at 4:00 p.m. EST.

A live webcast of the discussion will be available by visiting the Events section of the Day One Media & Investors page. An archived replay of the webcast will be available for 30 days following the live event.

About Day One Biopharmaceuticals
Day One Biopharmaceuticals believes when it comes to pediatric cancer, we can do better. The Company was founded to address a critical unmet need: the dire lack of therapeutic development in pediatric cancer. Inspired by “The Day One Talk” that physicians have with patients and their families about an initial cancer diagnosis and treatment plan, Day One aims to re-envision cancer drug development and redefine what’s possible for all people living with cancer—regardless of age—starting from Day One.

Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important targeted cancer treatments. The Company’s pipeline includes tovorafenib (OJEMDA™) and DAY301.

Day One is based in Brisbane, California. For more information, please visit www.dayonebio.com or find the Company on LinkedIn or X.

Day One uses its Investor Relations website (ir.dayonebio.com), its X handle (x.com/DayOneBio), and LinkedIn Home Page (linkedin.com/company/dayonebio) as a means of disseminating or providing notification of, among other things, news or announcements regarding its business or financial performance, investor events, press releases, and earnings releases, and as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD.

DAY ONE MEDIA
Laura Cooper, Head of Communications
media@dayonebio.com

DAY ONE INVESTORS
LifeSci Advisors, PJ Kelleher
pkelleher@lifesciadvisors.com

FAQ

When will Day One (DAWN) present at the Piper Sandler 37th Annual Healthcare Conference?

Day One management will present on Tuesday, December 2, 2025 at 4:00 p.m. EST.

How can investors watch the Day One (DAWN) fireside chat on December 2, 2025?

Investors can watch a live webcast via the Events section of the Day One Media & Investors page.

Will Day One (DAWN) provide a replay of the Piper Sandler conference webcast?

Yes. An archived replay will be available for 30 days following the live event.

What topics will Day One (DAWN) management cover in the Piper Sandler fireside chat?

The company said management will discuss recent developments and outlook; no additional topic specifics were provided.

Is the Day One (DAWN) webcast free to access for the public?

The webcast is available via the company’s Events page; no access fee was mentioned.

Where on Day One’s website will the Piper Sandler conference webcast be hosted?

The live webcast will be hosted in the Events section of the Day One Media & Investors page.